Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas S Heaton

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Nature Communications|October 8, 2024
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNARebecca A Leonard, Kaitlyn N Burke, Rachel L Spreng, et al.
Journal of Virology|July 21, 2022
A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in MiceRyan R Chaparian, Alfred T Harding, Cait E Hamele, et al.
Journal of Virology|October 10, 2024
Fluorescent and bioluminescent bovine H5N1 influenza viruses for evaluation of antiviral interventionsJoseph D Trimarco, M Ariel Spurrier, Samantha Skavicus, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2009
Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replicationKristi L Berger, Jacob D Cooper, Nicholas S Heaton, et al.
Journal of Virology|July 16, 2025
Development of DNA and mRNA-LNP vaccines against an H5N1 clade 2.3.4.4b influenza virusRebecca A Leonard, M Ariel Spurrier, Samantha Skavicus, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
The <i>Shigella flexneri</i> effector IpaH1.4 facilitates RNF213 degradation and protects cytosolic bacteria against interferon-induced ubiquitylationLuz Saavedra-Sanchez, Mary S Dickinson, Shruti Apte, et al.
Nature Communications|October 30, 2022
Cellular glycan modification by B3GAT1 broadly restricts influenza virus infectionJoseph D Trimarco, Sarah L Nelson, Ryan R Chaparian, et al.
Journal of Virology|January 10, 2025
The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activitySamantha L Grimes, Brook E Heaton, Mackenzie L Anderson, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activitySamantha L Grimes, Brook E Heaton, Mackenzie L Anderson, et al.
Elife|November 28, 2025
The <i>Shigella flexneri</i> effector IpaH1.4 facilitates RNF213 degradation and protects cytosolic bacteria against interferon-induced ubiquitylationLuz Saavedra-Sanchez, Mary S Dickinson, Shruti S Apte, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Nature Communications|October 8, 2024
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNARebecca A Leonard, Kaitlyn N Burke, Rachel L Spreng, et al.
Journal of Virology|July 21, 2022
A Virion-Based Combination Vaccine Protects against Influenza and SARS-CoV-2 Disease in MiceRyan R Chaparian, Alfred T Harding, Cait E Hamele, et al.
Journal of Virology|October 10, 2024
Fluorescent and bioluminescent bovine H5N1 influenza viruses for evaluation of antiviral interventionsJoseph D Trimarco, M Ariel Spurrier, Samantha Skavicus, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2009
Roles for endocytic trafficking and phosphatidylinositol 4-kinase III alpha in hepatitis C virus replicationKristi L Berger, Jacob D Cooper, Nicholas S Heaton, et al.
Journal of Virology|July 16, 2025
Development of DNA and mRNA-LNP vaccines against an H5N1 clade 2.3.4.4b influenza virusRebecca A Leonard, M Ariel Spurrier, Samantha Skavicus, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
The <i>Shigella flexneri</i> effector IpaH1.4 facilitates RNF213 degradation and protects cytosolic bacteria against interferon-induced ubiquitylationLuz Saavedra-Sanchez, Mary S Dickinson, Shruti Apte, et al.
Nature Communications|October 30, 2022
Cellular glycan modification by B3GAT1 broadly restricts influenza virus infectionJoseph D Trimarco, Sarah L Nelson, Ryan R Chaparian, et al.
Journal of Virology|January 10, 2025
The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activitySamantha L Grimes, Brook E Heaton, Mackenzie L Anderson, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
The coronavirus nsp14 exoribonuclease interface with the cofactor nsp10 is essential for efficient virus replication and enzymatic activitySamantha L Grimes, Brook E Heaton, Mackenzie L Anderson, et al.
Elife|November 28, 2025
The <i>Shigella flexneri</i> effector IpaH1.4 facilitates RNF213 degradation and protects cytosolic bacteria against interferon-induced ubiquitylationLuz Saavedra-Sanchez, Mary S Dickinson, Shruti S Apte, et al.
Pageof 9